COMPASS PATHWAYS PLC Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
COMPASS PATHWAYS PLC (CMPS) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of $774.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-03-24
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2024 was $774.00K, a 2245.45% increase from fiscal 2023.
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was $33.00K.
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2022 was -$782.00K.
- COMPASS PATHWAYS PLC effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2021 was -$8.30M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2024-12-31 | $774.00K 10-K · filed 2026-03-24 |
| 2023-12-31 | $33.00K 10-K · filed 2025-02-27 |
| 2022-12-31 | -$782.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | -$8.30M 10-K · filed 2024-02-29 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |